Advertisement

Rare Bleeding Disorders in Young Women

Published:October 11, 2010DOI:https://doi.org/10.1016/j.jpag.2010.08.011

      Abstract

      Rare bleeding disorders can cause significant bleeding in children and adolescents. These encompass rare clotting factor deficiencies, and fibrinolytic pathway defects. Vascular anomalies can cause recurrent and refractory bleeding, and are included in this review of rare causes of abnormal bleeding in children and adolescents. Menorrhagia is often reported as a manifestation of these conditions. Succinct knowledge about these disorders, their clinical presentation, diagnostic work-up, and therapeutic options are crucial to the accurate diagnosis and optimal management of affected patients. This review provides an overview of these infrequently encountered disorders, discusses their recognition based on results of suggested screening tests and offers a general guideline for approach to therapy.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mannucci P.M.
        • Duga S.
        • Peyvandi F.
        Recessively inherited coagulation disorders.
        Blood. 2004; 104: 1243
        • Acharya S.S.
        • Coughlin A.
        • Dimichele D.M.
        Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias.
        J Thromb Haemost. 2004; 2: 248
      1. Brooker M: Registry of clotting factor concentrates, (8th ed.). 2008. [Online] World Federation of Hemophilia.

        • Acharya S.S.
        • Dimichele D.M.
        Rare inherited disorders of fibrinogen.
        Haemophilia. 2008; 14: 1151
        • Bolton-Maggs P.H.
        Factor XI deficiency–resolving the enigma? Hematology Am Soc Hematol Educ Program. 2009; : 97
        • Brown D.L.
        • Kouides P.A.
        Diagnosis and treatment of inherited factor X deficiency.
        Haemophilia. 2008; 14: 1176
        • Hsieh L.
        • Nugent D.
        Factor XIII deficiency.
        Haemophilia. 2008; 14: 1190
        • Huang J.N.
        • Koerper M.A.
        Factor V deficiency: a concise review.
        Haemophilia. 2008; 14: 1164
        • Meeks S.L.
        • Abshire T.C.
        Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
        Haemophilia. 2008; 14: 1159
        • Spreafico M.
        • Peyvandi F.
        Combined FV and FVIII deficiency.
        Haemophilia. 2008; 14: 1201
        • Weston B.W.
        • Monahan P.E.
        Familial deficiency of vitamin K-dependent clotting factors.
        Haemophilia. 2008; 14: 1209
        • Mariani G.
        • Bernardi F.
        Factor VII Deficiency.
        Semin Thromb Hemost. 2009; 35: 400
        • Peyvandi F.
        • Haertel S.
        • Knaub S.
        • et al.
        Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia.
        J Thromb Haemost. 2006; 4: 1634
        • Hill M.
        • Dolan G.
        Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias.
        Haemophilia. 2008; 14: 889
        • Tziomalos K.
        • Vakalopoulou S.
        • Perifanis V.
        • et al.
        Treatment of congenital fibrinogen deficiency: overview and recent findings.
        Vasc Health Risk Manag. 2009; 5: 843
        • Ivaskevicius V.
        • Seitz R.
        • Kohler H.P.
        • et al.
        International registry on factor XIII deficiency: a basis formed mostly on European data.
        Thromb Haemost. 2007; 97: 914
        • Albisetti M.
        The fibrinolytic system in children.
        Semin Thromb Hemost. 2003; 29: 339
        • Mehta R.
        • Shapiro A.D.
        Plasminogen activator inhibitor type 1 deficiency.
        Haemophilia. 2008; 14: 1255
        • Repine T.
        • Osswald M.
        Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review.
        Clin Appl Thromb Hemost. 2004; 10: 293
        • Fay W.P.
        • Parker A.C.
        • Condrey L.R.
        • et al.
        Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene.
        Blood. 1997; 90: 204
        • Vijapurkar M.
        • Mota L.
        • Shetty S.
        • et al.
        Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
        Haemophilia. 2009; 15: 199
        • Johnson C.
        • Reid-Nicholson M.
        • Deligdisch L.
        • et al.
        Capillary hemangioma of the endometrium: a case report and review of the literature.
        Arch Pathol Lab Med. 2005; 129: 1326
        • Berry D.L.
        • DeLeon F.D.
        Endometrial ablation for severe menorrhagia in a patient with hereditary hemorrhagic telangiectasia. A case report.
        J Reprod Med. 1996; 41: 183
        • Shanberge J.N.
        Hemangioma of the uterus associated with hereditary hemorrhagic telangiectasia.
        Obstet Gynecol. 1994; 84: 708